Subscribe To
cingulate to host cns key opinion leader panel in new york city
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations KANSAS CITY, Kan., Oct. 17, 2023 (GL...
October 17, 2023, 6:22 pm
cingulate inc. to present at the ld micro main event xvi
Presentation on Wednesday, October 4th at 02:30 PM PT Kansas City, Kansas--(Newsfile Corp. - September 21, 2023) - ...
September 21, 2023, 11:23 am
cingulate announces detailed trial results from phase 3 adult efficacy and safety trial of ctx-1301 (dexmethylphenidate) for adhd
CTx-1301 Demonstrated Clinically Meaningful Improvements in Permanent Product Measure of Performance (PERMP) and Clinical Global Impression Scale (CGI...
September 11, 2023, 10:00 am
cingulate to participate in the healthcare virtual conference part ii presented by maxim group and hosted by m-vest
KANSAS CITY, Kan., June 14, 2023 (GLOBE NEWSWIRE) — cingulate Inc. (NASDAQ: CING), a biopharmaceutica...
June 14, 2023, 7:45 pm
cingulate to participate in the healthcare virtual conference part ii presented by maxim group and hosted by m-vest
KANSAS CITY, Kan., June 14, 2023 (GLOBE NEWSWIRE) -- cingulate Inc. (NASDAQ: CING), a biopharmaceutical...
June 14, 2023, 3:45 pm
cingulate to present at 13th annual ld micro invitational
KANSAS CITY, Kan., May 25, 2023 (GLOBE NEWSWIRE) — cingulate Inc. (NASDAQ: CING), a biopharmaceutical...
May 25, 2023, 7:55 pm
cingulate to present at 13th annual ld micro invitational
KANSAS CITY, Kan., May 25, 2023 (GLOBE NEWSWIRE) -- cingulate Inc. (NASDAQ: CING), a biopharmaceutical ...
May 25, 2023, 3:55 pm
Cingulate, indegene to participate in benzinga all live access event
KANSAS CITY, Kan., May 12, 2023 (GLOBE NEWSWIRE) — cingulate Inc. (NASDAQ: CING), a biopharmaceutical...
May 12, 2023, 7:45 pm
cingulate announces successful transfer of ctx-1301 (dexmethylphenidate) proprietary ptr™ manufacturing processes to societal cdmo
Scalable Supply of CTx-1301 Ready to be Produced with cingulate on Track to Meet Previously Announced C...
May 3, 2023, 10:45 am
Why is cingulate (cing) stock up 72% today?
cingulate (NASDAQ: CING ) stock is on the rise Friday after releasing positive data concerning its ADHD...
February 24, 2023, 7:47 am
cingulate initiates phase 3 study of lead asset ctx-1301, designed as a true entire active-day treatment for adhd
Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in Sa...
January 4, 2023, 11:45 am
cingulate to participate in benzinga all live access event
KANSAS CITY, Kan., Nov. 30, 2022 (GLOBE NEWSWIRE) — cingulate Inc. (NASDAQ: CING), a biopharmaceutica...
November 30, 2022, 8:00 pm
cingulate inc. to present at investor summit group's q4 conference
Kansas City, Kansas--(Newsfile Corp. - November 3, 2022) - cingulate Inc. (NASDAQ: CING), a biopharmace...
November 3, 2022, 7:00 am
cingulate to present at h.c. wainwright global investment conference
KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- cingulate Inc. (NASDAQ: CING), a clinical-stage bio...
May 18, 2022, 5:20 pm
cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies
cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...
February 8, 2022, 12:20 pm
cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies
cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...
February 8, 2022, 12:20 pm
cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies
cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...
February 8, 2022, 12:20 pm